Data from Sweden Used to Examine PPI Use, Risk of Fracture in Children

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 16, 2020

Media Advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.0007?guestAccessKey=a520fce8-1f53-4ed9-8bc7-9c4c0e461cf8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031620

 

What The Study Did: Data from Sweden were used to compare 115,933 pairs of children who did or didn’t use proton pump inhibitors (PPIs) to examine the association between PPI use and risk of fracture in children.

Author: Yun-Han Wang, M.Sc., B.Pharm., of the Karolinska Institutet in Stockholm, Sweden, is the corresponding author.

 

(doi:10.1001/jamapediatrics.2020.0007)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.